Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Key Insights iX Biopharma's significant insider ownership suggests inherent interests in company's expansion 51% of the...
While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.